Dr Sandy Hamilton

  • About
  • Selected Publications
  • Awards

 

 POCHE Research Fellow                                                                               

 RN, PhD

P: (08) 9956 0231
F: (08) 9934 6034
M: 0421 231954
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Professional background  

Dr Hamilton is the WACRH Poche Research Fellow of the UWA Poche Centre with a focus on health service interventions for better prevention and management of chronic disease for Aboriginal people. 

Sandy is an experienced registered nurse who undertook her nursing training in New Zealand where there was a high focus on cultural safety in the delivery of health care. She has many years of experience working as a research nurse and completed her PhD through the University of Western Australia. She has extensive experience in cardiology, cardiovascular prevention and cardiovascular and diabetes research.  Since 2011 Sandy has worked as an academic and researcher at the West Australian Centre for Rural Health (WACRH) in Geraldton.  

Sandy has a strong commitment to the prevention and management of chronic disease, including self-management, health promotion, health service research and effective knowledge exchange (research translation) for Aboriginal people.   

Research interests 

Her research interests have been focused on primary and secondary cardiovascular prevention including cardiac rehabilitation, family health history, and research translation. She is working in collaboration with the Heart Foundation undertaking a scoping consultation with a view to improving access to cardiac rehabilitation services for Aboriginal people in the Pilbara. In her role as the Poche Fellow, Sandy will extend her focus to other chronic diseases, particularly cancer and work towards health service strengthening for improved access and for Aboriginal people around chronic disease.  

Memberships / Affiliations 

  • Australian Cardiovascular Health and Rehabilitation Association

  • Australian College of Nurses

  • Australasian Cardiovascular Nurses College

  • Preventative Cardiovascular Nursing Association

  • Australian Atherosclerosis Society

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected Publications

Book chapter

Hamilton, SJ, Watts, GF. Endothelial dysfunction and dyslipidaemia in type 2 diabetes: pathogenesis, significance and therapy. Jenkins A, Toth P, and Lyon's T editors   "Lipoproteins in Diabetes Mellitus." Humana Press Inc. 2014. 

Major reviews

Hamilton SJ, Watts GF. Endothelial Dysfunction in Diabetes: Pathogenesis, Significance and Treatment. Rev Diabet Stud 2013; 10:129-152.   

Hamilton SJ, Watts GF. Atherogenic Dyslipidaemia and Combination Pharmacotherapy in Diabetes: Recent Clinical Trials. Rev Diabet Stud 2013; 10:191-203. 

Hamilton, SJ, Chew, GT, Watts, GF: Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diabetes Vasc Dis Res 2007; 4: 89-102,

Journal Articles

Bates TR, Burnett JR, Bockxmeer, FM, Hamilton, S, Arnolda, L, Watts, GF: Detection of Familial Hypercholesterolaemia: A Major Treatment Gap in Preventative Cardiology. Heart, Lung and Circulation  2008; 17: 411-413

Hamilton, SJ, Chew, GT, Watts, GF: Coenzyme Q10 supplementation improves endothelial dysfunction in statin-treated Type 2 diabetic patients. Diabetes Care 2009; 32: 810-812.

Hamilton, SJ, Watts, GF. Coenzyme Q10 Supplementation and Statins. Cardiology in General Practice (2009); 10: 24

Watts, GF, Hamilton, SJ. Radical Therapy for Hypercholesterolaemia. Cardiology in General Practice (2009); 8: 6-7

Watts, GF, Hamilton, SJ.  LDL Apheresis for Familial Hypercholesterolaemia: value, indications and demand. Clin Lipidol 2009; 4(2): 129-131.

Hamilton SJ, Chew GT, Davis TME, Watts GF. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients. Clin Sci 2010; 118(10):607-615.

Chan DC, Hamilton SJ, RYE KA, Chew GT, Jenkins AJ, Lambert G, Watts GF: Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients. Diabetes, Obesity and Metabolism 2010; 12:752-756.

Hamilton SJ, Chew GT, Davis TME, Watts GF.  Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patients. Diabetes and Vascular Disease Research 2010; 7(4): 296-299.

Hamilton SJ, Chew GT, Davis TME, Stuckey BGA, Watts GF. Hypertriglyceridaemia in statin-treated type 2 diabetic patients. Practical Diabetes 2011; 28: 257-260.

Hamilton SJ, Chew GT, Davis TME, Watts GF. Prevalence and predictors of abnormal arterial function in statin-treated type 2 diabetic patients. Metabolism 2012; 61: 349-357.

Pang J, Chan DC, Hamilton SJ, Tenneti VS, Watts GF, Barrett PHR. Effect of Niacin on HDL ApoA-I Kinetics in Statin-treated Patients with Type 2 Diabetes. Aterioscler, Thromb and Vasc Biol 2014; 34(2): 427-432.

Page A, Hall M, Fitzgerald K, Hamilton S, Warner W, Holloway M, Thompson S. Gaining a proper sense of what happens out there: An Academic Bush Camp to promote rural placements for students. Australian Journal of Rural Health. 2014. Accepted for publication

Manuscripts Submitted for Publication

Deek H, Hamilton SJ, Brown N, Inglis S, DiGiacomo M, Newton PJ, Noureddine S, Davidson PM. Family-based approaches to Health care interventions in chronic disease: a review. International Journal of Nursing Studies 2013. Submitted 30 Sept 2013.

Abstracts

James, A. Mamo, J. Barrett, H. Hamilton, S. Watts, S. The Effect of insulin sensitisers on postprandial lipid metabolism in obese, insulin resistant subjects. Atherosclerosis 2003; 4 (September Suppl): 128.

Hamilton, SJ, Chew, GT, Davis, TME, Watts, GF. Fenofibrate improves endothelial function in both conduit and resistance arteries in statin-treated type 2 diabetics. Heart, Lung and Circulation 2009;18:S242.

Hamilton, SJ, Chew, GT, Davis, TME, Watts, GF. Niacin improves microcirculatory endothelial dysfunction and arterial compliance in statin-treated type 2 diabetic subjects. Heart, Lung and Circulation 2009;18:S245.

Hamilton, S, Chew, G, Watts, G. Heart, Prevalence and Predictors of ‘Residual Risk’ in Statin-treated Type 2 Diabetic Patients: Implications for nurse led interventions. Lung and Circulation 2010;19:S7.

Conference Presentations

Oral Presentations

Australian Atherosclerosis Association: Short-term supplementation with Coenzyme Q10 (CoQ) does not improve endothelial dysfunction in type 2 diabetes, October 2006.

PPCN Education Session: Statin Intolerance, September 2008.

PPCN Education Session: Statin Intolerance, November 2008.

Cardiac Society of Australia and New Zealand: Niacin Improves Microcirculatory Endothelial Dysfunction and Arterial Compliance in Statin-treated Type 2 Diabetic. August 2009.

Cardiac Society of Australia and New Zealand: Fenofibrate Improves Endothelial Function in Both Conduit and Resistance Arteries in Statin-treated Type 2 Diabetics. August 2009.

Australian Atherosclerosis Association: Prevalence and Predictors of ‘Residual Risk’ in Statin-treated Type 2 Diabetic Patients: A Cross-sectional Study Based on Flow Mediated Dilatation. October 2009.

Australasian Cardiovascular Nurses College: Prevalence and Predictors of ‘Residual Risk’ in Statin-treated Type 2 Diabetic Patients: Implications for nurse led interventions. March 2010.

Finalist in the Affiliate Nursing Prize, Cardiac Society of Australia and New Zealand: Prevalence and Predictors of ‘Residual Risk’ in Statin-treated Type 2 Diabetic Patients: Implications for nurse led interventions. August 2010.

Poster Presentations

1.  School of Medicine and Pharmacology, Faculty of Medicine, Dentistry and Health Sciences, Annual ResearchDay: Coenzyme Q10 supplementation improves endothelial dysfunction in statin-treated Type 2 diabetic patients. October 2008

2.  Australian Atherosclerosis Society:  Coenzyme Q10 supplementation improves endothelial dysfunction in statin-treated Type 2 diabetic patients. October 2008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Awards

Australian Atherosclerosis Association Student Travel Award, Australian Atherosclerosis Society (AAS), 2006, 2008 and 2009.

Poster award: Coenzyme Q10  supplementation improves endothelial dysfunction in statin- treated  type 2 diabetic patients (Poster presentation at, School of Medicine and Pharmacology, Annual Research Day, Royal Perth Hospital October 2008).

Oral presentation award: Prevalence and Predictors of ‘Residual Risk’ in Statin-treated Type 2 Diabetic Patients: Implications for Nurse-led Interventions (Oral presentation at Australasian Cardiovascular Nursing College Conference, March 2010).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quick Menu

  • Poche Centre for Indigenous Health >

    The Centre aims to drive a transformative intergenerational Aboriginal health research agenda. Read More
  • Cultural Orientation >

    A number of universities in WA have adopted WACRH's Cultural Orientation site as part a Read More
  • Staff Contacts & Profiles >

    WACRH staff are based in Geraldton, Perth , Karratha and Mt Magnet. Read More
  • Staff Webmail >

    WACRH Staff Webmail Read More
  • Intranet >

    Staff Access Read More
  • 1
  • 2